General Information
Revision date
2015-05-05
Product name
0.6% as base
1.2.1 Relevant identified uses
l Finshed Pharmaceutical Product; Besivance® (besifloxacin ophthalmic suspension) 0.6%, is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates
1.2.2. Uses advised against
l Refer to the product insert and/or prescribing information for restrictions on use and contraindications
Manufacturer Name
l Bausch & Lomb
Icons in SDS
Company Information
company name
l Bausch & Lomb
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)
2.1 Classification of the substance or mixture
UN GHS l Acute Toxicity Oral 5 Eye Mild Irritation 2B
2.2 Label elements
UN GHS WARNING
Hazard statements
May cause eye irritation in sensitive individuals May be harmful if swallowed
Precautionary statements
Prevention l Use only in accordance with label instructions and supplied prescibing information. base Wash thoroughly after handling. Response l IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. If eye irritation persists: Get medical advice/attention. IF ON SKIN: Wash with plenty of soap and water. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Storage/Disposal l Keep tightly closed. Store at room temperature 1525ºC (5977ºF), to maintain product integrity. Use before date marked on carton and/or container. Store protected from light and heat. Dispose of content and/or container in accordance with local, regional, national, and/or international regulations.
2.3 Other hazards
UN GHS l No data available
